EGFR Positive Non-small Cell Lung Cancer (2)

EGFR Positive Non-Small Cell Lung Cancer (1)

NSCLC Stage IIIB (1)

NSCLC Stage IIIC (1)

NSCLC Stage IV (1)

Non-small Cell Lung Cancer Stage III (1)

Non-squamous Non-small-cell Lung Cancer (1)

Recurrent NSCLC (1)

Active, not recruiting (2)

Recruiting (1)

phase 2 (3)

Korea University Guro Hospital (1)

National Cancer Centre, Singapore (1)

Sung Yong Lee (1)

Chong Kun Dang Pharmaceutical Corp. (1)

Pfizer (1)

Yuhan Corporation (1)

dacomitinib (1)

egfr (1)

lazertinib (1)

drug (3)

Other (3)

Interventional (3)

EGFR Positive Non-small Cell Lung Cancer

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS